NPI: 1114325644 · FRANKLIN, VA 23851 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/16/2014
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 12/16/2014 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,779 | $101K |
| 2019 | 15,302 | $110K |
| 2020 | 13,100 | $246K |
| 2021 | 14,599 | $289K |
| 2022 | 12,719 | $365K |
| 2023 | 7,460 | $330K |
| 2024 | 1,495 | $79K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,622 | 1,786 | $1.50M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 25,175 | 1,004 | $14K |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,422 | 780 | $4K |
| J1756 | Injection, iron sucrose, 1 mg | 3,326 | 587 | $634.68 |
| 90662 | 28 | 14 | $77.15 | |
| 83970 | 436 | 222 | $76.30 | |
| 82728 | 343 | 175 | $20.33 | |
| 85041 | 890 | 444 | $16.72 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 35 | 12 | $16.48 |
| 85048 | 866 | 431 | $13.97 | |
| 83550 | 351 | 176 | $13.26 | |
| A4657 | Syringe, with or without needle, each | 4,534 | 1,183 | $10.44 |
| 83540 | 352 | 176 | $10.07 | |
| G0008 | Administration of influenza virus vaccine | 74 | 42 | $6.24 |